The Impact Of Art On Wellbeing In Autoimmune Disease PDF Print E-mail
Tuesday, 25 October 2011 09:11
taken from http://www.flickr.com/photos/georgiap/2230846846/ via creative commonsAn innovative Newcastle research project is measuring the impact of creating art on the symptoms and overall wellbeing of people living with an autoimmune illness.

A team at the University of Newcastle, in conjunction with the Autoimmune Resource and Research Centre at John Hunter Hospital, is working with participants with a range of autoimmune illnesses including Lupus, Scleroderma, Rheumatoid Arthritis and Sjögren's syndrome. Dr Kathryn Grushka from the University said the team was monitoring improvements to participants’ sense of wellbeing and measureable indicators of health, particularly levels of stress.

“Stress is a major flare factor for autoimmune illnesses. We are testing levels of the stress hormone cortisol by taking saliva samples before and after artmaking workshops,” Dr Grushka said.

Participants’ quality of life and functionality is being measured by reviewing digital and written diaries and through standard health assessments, such as testing mobility, blood pressure and heart rate.

The study consists of artists, non-artists and those without an autoimmune illness, with all participants asked to produce artworks based on personal experiences. The results are due to be published in early 2012.

Work created through the project will be displayed in the halls of John Hunter Hospital from Tuesday 4 October, Lupus awareness month, until January 2012 as part of Hunter New England Health’s ‘Arts for Health Program’.

 
More articles :

» Making A Difference

, a Center for Student Missions team member, recently recounted a touching experience, in which she heard about and met someone with Scleroderma for the very first time. According to Jessica, "We don't always get to see the effect of what it is we...

» Prevention Of Vascular Damage In Scleroderma With Angiotensin-converting Enzyme (ACE) Inhibition

Great strides have been made in identifying and managing the organ-based complications of  systemic sclerosis (SSc). There is no room for the nihilism towards treating this disease that used to be so prevalent. However, there is still...

» U.S. Legislation Passed to Promote Research and Awareness of Scleroderma

(U.S.) has applauded the U.S. House of Representatives for the passage of the Scleroderma Research and Awareness Act (H.R. 2408), introduced last March by Rep. Lois Capps (D-CA) and Rep. Vern Ehlers (R-MI). This bipartisan legislation gives hope to...

» The FDA Approves IV Sildenafil for Hypertension

The FDA has approved an intravenous formulation of the pulmonary arterial hypertension drug sildenafil (Revatio) for patients who are temporarily unable to take the medication in its oral form. The tablet form of sildenafil was approved in 2005 to...

» Survival In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc) and one of the leading causes of morbidity and mortality in this disease. Although several recent studies have suggested an improvement in the prognosis of...

» 5 Easy Steps to a Healthier You

Trying to alter your habits and routines can be daunting, even when you know the changes are for the better. Here’s a modest program that will help you get on track without feeling overwhelmed:Week 1 — Drink a lot more water this week. In...